An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

Speciality: Hematology


Speaker:

Prof. Dr. Christian Breymann | Specialist in Gynecology and Obstetrics, Perinatal Zurich

Description:

A warm welcome to all the medical professionals to this highly anticipated panel discussion on "An Eagle's View - Evidence-based Discussion on Iron Deficiency Anemia." Following our in-depth look at IDA, this session offers a unique opportunity for a dynamic and interactive exchange among experts. The goal is to address the multifaceted challenges in diagnosing and treating IDA in various patient populations, from managing comorbidities to navigating treatment resistance. 

This panel will delve into pressing questions that arise in clinical practice. Topics will include the most effective strategies for iron repletion in patients with chronic inflammatory conditions, such as inflammatory bowel disease, where oral iron absorption is often impaired. The experts will also discuss the optimal use of intravenous iron formulations, considering factors like dosing, patient safety, and the cost-benefit analysis in different healthcare settings. This discussion will highlight the importance of personalized, evidence-based decision-making. 

Therefore, get an overall knowledge of how to apply an evidence-based approach to the complexities of iron deficiency anemia in a panel discussion format. Absorb the shared knowledge, get your questions answered by experts, and follow Hidoc for more such insightful webinar sessions.
 


See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

2.

A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.

3.

Nearly 4 million lung cancer deaths averted and 76 million years of life gained due to tobacco control in US

4.

Targeted Combination Shows Promise in Metastatic Kidney Cancer

5.

Through Consolidation Durvalumab, Limited-Stage SCLC Receives a New Standard of Care.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot